ExSight Ventures
Overview
ExSight Ventures is a venture capital firm specializing in early-stage investments in innovative ophthalmic diagnostic and treatment solutions. The firm was established to address the lack of early-stage funding in the life sciences sector, particularly within ophthalmology. Comprising two accomplished retinal surgeons and a team of investment professionals, ExSight Ventures focuses on biotechnology, medical devices, pharmaceuticals, and software solutions with ophthalmic applications. The firm's investment strategy is centered on capital efficiency and deep domain expertise. By investing in pre-seed to Series B rounds, ExSight Ventures aims to generate substantial value at formative stages. Their specialization in ophthalmology allows for efficient analysis of early-stage risks and the ability to assist portfolio companies in focusing their pre-clinical and clinical efforts effectively. This approach differentiates them from larger funds that dominate healthcare venture capital. ExSight Ventures' commitment to advancing innovation in eye care is evident through its investments in companies like DefEYE, Inc., which is developing decellularized placental-based tissue solutions for ocular surface disease and surgical management. This investment underscores ExSight Ventures' dedication to supporting transformative technologies that aim to preserve and restore vision.
Investment Focus
- Innovative ophthalmic diagnostic and treatment solutions
- Early-stage companies
- Capital-efficient business models
Portfolio Companies
Get the full list of 54,000+ investors
ExSight Ventures and every other firm and angel in the database — as one spreadsheet you keep.
$19one-time payment · no subscription- All 54,000+ investors — VC firms, private equity, family offices and angels
- The key person to contact at each one, with their job title
- Their work email address
- Their phone number
- Their LinkedIn profile
- Delivered as a single .xlsx file — download it as many times as you like
Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.
Frequently asked questions about ExSight Ventures
What sectors does ExSight Ventures invest in?
ExSight Ventures invests in Pharmaceuticals, Medical Devices, Biotechnology, Ophthalmology and Software Solutions, and is based in New York, United States. ExSight Ventures is listed as a vc in the ConnectSafely investor database.
What stage does ExSight Ventures invest at?
ExSight Ventures backs companies at Pre-Seed, Seed, Early Stage, Series A and Series B, writing cheques of 1M - 10M.
Which regions does ExSight Ventures invest in?
ExSight Ventures invests across United States.
Who are the partners at ExSight Ventures?
Team members listed for ExSight Ventures include James Murray (Partner) and Alan Spiro (Partner).
What companies has ExSight Ventures invested in?
ExSight Ventures's portfolio includes DefEYE, Inc. and RevOpsis Therapeutics.
How do I contact ExSight Ventures?
ExSight Ventures's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database